CytoMed Therapeutics
GDTC
#10185
Rank
$18.27 M
Marketcap
$1.56
Share price
0.47%
Change (1 day)
-43.37%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for CytoMed Therapeutics CIK: 0001873093
The 20-F is a 10-K equivalent for non-US companies, as a foreight company CytoMed Therapeutics only files 20-F reports

Thumbnail CytoMed Therapeutics 20-F Annual Report 2024

20-F Annual Report 2024

Language: English

View Annual Report (20-F)
Thumbnail CytoMed Therapeutics 20-F Annual Report 2023

20-F Annual Report 2023

Language: English

View Annual Report (20-F)
Thumbnail CytoMed Therapeutics 20-F Annual Report 2022

20-F Annual Report 2022

Language: English

View Annual Report (20-F)